US Patent

US9169238 — Solid pharmaceutical composition

Formulation · Assigned to Takeda Pharmaceutical Co Ltd · Expires 2030-02-04 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a solid pharmaceutical composition containing a specific compound, a pH control agent, and a diuretic.

USPTO Abstract

The present invention relates to a solid preparation containing a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof, a pH control agent and a diuretic, which is superior in the stability and dissolution property of the compound represented by the formula (I) and the diuretic.

Drugs covered by this patent

Patent Metadata

Patent number: US9169238
Jurisdiction: US
Classification: Formulation
Expires: 2030-02-04
Drug substance claim: No
Drug product claim: Yes
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.